Nisa Investment Advisors LLC Sells 4,837 Shares of Cigna Group $CI

Nisa Investment Advisors LLC lessened its holdings in shares of Cigna Group (NYSE:CI) by 4.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 96,704 shares of the health services provider’s stock after selling 4,837 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Cigna Group were worth $26,287,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in CI. BlackRock Inc. grew its position in Cigna Group by 3.7% during the second quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider’s stock valued at $6,461,457,000 after purchasing an additional 840,098 shares in the last quarter. GQG Partners LLC acquired a new position in Cigna Group in the 2nd quarter valued at approximately $1,628,918,000. Bank of America Corp DE increased its stake in Cigna Group by 8.8% in the 1st quarter. Bank of America Corp DE now owns 3,182,083 shares of the health services provider’s stock valued at $848,821,000 after buying an additional 256,677 shares during the period. Dimensional Fund Advisors LP lifted its position in Cigna Group by 10.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,426,218 shares of the health services provider’s stock worth $647,008,000 after buying an additional 236,340 shares in the last quarter. Finally, Legal & General Group Plc acquired a new stake in shares of Cigna Group during the 2nd quarter valued at $542,779,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insiders Place Their Bets

In other news, insider Everett Neville sold 617 shares of the firm’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the transaction, the insider owned 5,053 shares in the company, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 19,436 shares of Cigna Group stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,730 shares of company stock worth $6,293,359 in the last 90 days. 0.60% of the stock is owned by insiders.

Cigna Group Price Performance

Shares of CI opened at $304.74 on Thursday. The firm has a market cap of $80.53 billion, a PE ratio of 12.61, a PEG ratio of 1.03 and a beta of 0.29. The firm’s 50 day moving average price is $280.49 and its 200 day moving average price is $282.73. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a twelve month low of $239.51 and a twelve month high of $311.34.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The firm had revenue of $71.56 billion during the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company’s revenue was up 6.7% compared to the same quarter last year. During the same period in the previous year, the company earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts expect that Cigna Group will post 30.50 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

CI has been the topic of several research analyst reports. Evercore assumed coverage on shares of Cigna Group in a report on Wednesday, September 9th. They set an “in-line” rating and a $290.00 price target on the stock. Raymond James Financial lowered Cigna Group from a “strong-buy” rating to an “outperform” rating and cut their price objective for the stock from $350.00 to $320.00 in a report on Monday, August 3rd. Sanford C. Bernstein reissued an “outperform” rating on shares of Cigna Group in a research report on Friday, October 2nd. Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, September 26th. Finally, Guggenheim upped their target price on Cigna Group from $338.00 to $361.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cigna Group currently has an average rating of “Moderate Buy” and a consensus price target of $338.24.

Cigna Group Company Profile

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.